Valsartan extends recall of popular blood-pressure drug


Mylan N.V. has drastically expanded its recall of high-blood-pressure medications containing Valsartan because tests have found trace amounts of a possible cancer-causing chemical. The latest recall adds 104 lots of drugs to those already recalled.

The recalls began after tests found trace amounts of an impurity, N-nitrosodiethylamine (NDEA), a substance tat occurs naturally in some foods, drinking waster, air pollution and industrial processes. It has been declared a “probable human carcinogen” by the  International Agency for Research on Cancer (IARC).

Our content partner Rx411 says there is speculation that NDEA may be a byproduct of the manufacturing process, rather than a contaminant from an external source. Read the full story here.


About the Author

Truman Lewis
A former reporter and bureau chief, Truman Lewis has covered presidential campaigns, state politics and stories ranging from organized crime to environmental and consumer protection.